DXCM
DexCom Inc (DXCM) Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
DexCom Inc (NASDAQ: DXCM) FY 2026 Other Release
DexCom Inc (DXCM) Q4 2025 Earnings Call Transcript
DexCom Inc (NASDAQ: DXCM) Q4 2025 Earnings Call dated Feb. 12, 2026 Corporate Participants: Sean Christensen — Vice President of…
DexCom Inc (DXCM) Sec Form 8K
DexCom Inc (NASDAQ: DXCM) Sec Form 8K
DexCom Inc (DXCM) Sec Form 8K
DexCom Inc (NASDAQ: DXCM) Sec Form 8K
DexCom Inc (DXCM) Dexcom Appoints Rick Osterloh to Board of Directors
DexCom Inc (NASDAQ: DXCM) FY 2026 Management Update
DexCom Inc (DXCM) 47th Annual Raymond James Institutional Investors Conference
DexCom Inc (NASDAQ: DXCM) FY 2026 Corporate Conference
DexCom Inc (DXCM) Sec Form 10K
DexCom Inc (NASDAQ: DXCM) Sec Form 10K
DexCom Inc (DXCM) Sec Form 8K
DexCom Inc (NASDAQ: DXCM) Sec Form 8K
DexCom Inc (DXCM) Q4 2025 Earnings Results
DexCom Inc (NASDAQ: DXCM) Q4 2025 Earnings Release
DexCom Inc (DXCM) Q4 2025 Earnings Call
DexCom Inc (NASDAQ: DXCM) Q4 2025 Earnings Conference